Clinical trial
Mitochondrial Dysfunction in the Pathophysiology and Treatment of Bipolar…
NCT00327756 · National Institute of Mental Health (NIMH), NIH · Withdrawn
Key facts
| NCT number | NCT00327756 |
|---|---|
| Title | Mitochondrial Dysfunction in the Pathophysiology and Treatment of Bipolar Disorder |
| Official title | An Investigation Examining the Evidence for Mitochondrial Dysfunction in the Pathophysiology and Treatment of Bipolar Disorder |
| Lead sponsor | National Institute of Mental Health (NIMH), NIH |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Bipolar Affective Disorder, Depression |
| Intervention type | Drug |
| Interventions | Coenzyme Q10 |
| Enrollment | 0 |
| Start date | May 1, 2006 |
| Primary completion | May 1, 2009 |
| First posted | May 19, 2006 |
| Last update posted | Nov 23, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: